D Chandramohan, A Dicko, I Zongo, I Sagara… - BMJ open, 2020 - bmjopen.bmj.com
Introduction Seasonal malaria chemoprevention (SMC), with sulphadoxine–pyrimethamine plus amodiaquine (SP+ AQ) is effective but does not provide complete protection against …
S Nikiema, I Soulama, S Sombié… - Infection and Drug …, 2022 - Taylor & Francis
Abstract Seasonal Malaria Chemoprevention (SMC), which combines amodiaquine (AQ) with sulfadoxine-pyrimethamine (SP), is an effective and promising strategy, recommended …
TS Amouh, SM Ekoye, CD Ahanhanzo, TR Guiguemdé… - Malaria Journal, 2021 - Springer
Background To strengthen the fight against malaria, it is imperative to identify weaknesses and possible solutions in order to improve programmes implementation. This study reports …
YB Cheung, X Ma, KF Lam, P Milligan - Vaccine, 2020 - Elsevier
Background An effective malaria vaccine affects the risk of malaria directly, through the vaccine-induced immune response (the primary effect), and indirectly, as a consequence of …
Le paludisme est une pathologie tropicale (décrite par Hippocrate depuis cent ans avant Jésus Christ), ayant traversée des siècles sans jamais perdre son activité. Il sévit sur un …
T Masserey, L Braunack-Mayer, RS Miller, JJ Moehrle… - osf.io
Sulfadoxine-pyrimethamine (SP) is the standard of care for Plasmodium falciparum malaria chemoprevention among pregnant women, infants, and children. However, SP's antimalarial …
S Nikiema, I Soulama, S Sombié, AM Tchouatieu… - 2022 - academia.edu
Abstract Seasonal Malaria Chemoprevention (SMC), which combines amodiaquine (AQ) with sulfadoxinepyrimethamine (SP), is an effective and promising strategy, recommended …
Artemisinin susceptibility in Plasmodium falciparum is modulated by mutations in the gene pfk13, which encodes a kelch propeller domain protein of unknown function. Reduced …
Mémoire de fin cycle Master en santé communautaire Page 1 Ministère de l’Enseignement REPUBLIQUE DU MALI Supérieur et de la Recherche Un Peuple – Un But – Une Foi Scientifique …